Company Profiles

driven by the PitchBook Platform

Tolera Therapeutics

Description

Developer of immune modulation transplant therapies. The company develops products to aid patients in anti-rejection therapy, immune modulation and oncology. Its products primarily serve the organ transplant, immune modulation and oncology markets.

2007

Founded

PRIVATE

Status

11-50

Employees

Conv. Debt

Latest Deal Type

$1.3M

Latest Deal Amount

$19M

Total Amount Raised

Description

Developer of immune modulation transplant therapies. The company develops products to aid patients in anti-rejection therapy, immune modulation and oncology. Its products primarily serve the organ transplant, immune modulation and oncology markets.

Website:

www.tolera.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Pharmaceuticals

Primary Office

P.O. Box 970 Portage, MI 49081United States +1 (269) 585-2100
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Tolera Therapeutics's full profile, request a free trial.

Tolera Therapeutics Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Tolera Therapeutics Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Tolera Therapeutics Investors (9)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Apjohn VenturesVenture CapitalMinority000 0000000 0000
Biosciences Research and Commercialization CenterVenture CapitalMinority000 0000000 0000
Cleveland Clinic Health SystemCorporate Venture CapitalMinority000 0000000 0000
Grand AngelsAngel GroupMinority000 0000000 0000
Hopen Life Science VenturesVenture CapitalMinority000 0000000 0000
Apjohn Ventures Venture Capital
Biosciences Research and Commercialization Center Venture Capital
Cleveland Clinic Health System Corporate Venture Capital
Grand Angels Angel Group
Hopen Life Science Ventures Venture Capital

Tolera Therapeutics Executive Team (3)

NameTitleBoard
Seat
Contact
Info
Harry Ledebur Ph.DChief Executive Officer & Board Member
Melissa VrbaProject Manager
Suzette DutchChairman
Harry Ledebur Ph.D Chief Executive Officer & Board Member
Melissa Vrba Project Manager
Suzette Dutch Chairman

Tolera Therapeutics Board Members (6)

NameRepresentingRoleSinceContact
Info
Donald ParfetApjohn VenturesBoard Member000 0000
Douglas Morton Ph.DSelfBoard Member000 0000
Harry Ledebur Ph.DTolera TherapeuticsChief Executive Officer & Board Member000 0000
Mark OlesnavageHopen Life Science VenturesBoard Member000 0000
Paul D'AmatoGrand AngelsBoard Observer000 0000
Donald Parfet Board Member Apjohn Ventures
Douglas Morton Ph.D Board Member Self
Harry Ledebur Ph.D Chief Executive Officer & Board Member Tolera Therapeutics
Mark Olesnavage Board Member Hopen Life Science Ventures
Paul D'Amato Board Observer Grand Angels
Request full access to PitchBook